166 related articles for article (PubMed ID: 35906487)
1. Morphological features of 52 cases of breast phyllodes tumours with local recurrence.
Bi J; Tang H; Lin X; Yu X; Liang Y; Zhang L; Li Z; Shao M
Virchows Arch; 2022 Oct; 481(4):519-531. PubMed ID: 35906487
[TBL] [Abstract][Full Text] [Related]
2. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
3. Detailed DNA methylation characterisation of phyllodes tumours identifies a signature of malignancy and distinguishes phyllodes from metaplastic breast carcinoma.
Meyer B; Stirzaker C; Ramkomuth S; Harvey K; Chan B; Lee CS; Karim R; Deng N; Avery-Kiejda KA; Scott RJ; Lakhani S; Fox S; Robbins E; Shin JS; Beith J; Gill A; Sioson L; Chan C; Krishnaswamy M; Cooper C; Warrier S; Mak C; Rasko JE; Bailey CG; Swarbrick A; Clark SJ; O'Toole S; Pidsley R
J Pathol; 2024 Apr; 262(4):480-494. PubMed ID: 38300122
[TBL] [Abstract][Full Text] [Related]
4. Can phyllodes tumours of the breast be distinguished from fibroadenomas using fine needle aspiration cytology?
Scolyer RA; McKenzie PR; Achmed D; Lee CS
Pathology; 2001 Nov; 33(4):437-43. PubMed ID: 11827409
[TBL] [Abstract][Full Text] [Related]
5. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
Silverman JS; Tamsen A
Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
[TBL] [Abstract][Full Text] [Related]
6. Cytological Criteria to Distinguish Phyllodes Tumour of the Breast from Fibroadenoma.
Maritz RM; Michelow PM
Acta Cytol; 2017; 61(6):418-424. PubMed ID: 28738381
[TBL] [Abstract][Full Text] [Related]
7. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
[TBL] [Abstract][Full Text] [Related]
8. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues.
Seow DYB; Tay TKY; Tan PH
Semin Diagn Pathol; 2022 Sep; 39(5):333-343. PubMed ID: 35523613
[TBL] [Abstract][Full Text] [Related]
9. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
Lee AH; Hodi Z; Ellis IO; Elston CW
Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
[TBL] [Abstract][Full Text] [Related]
10. Fibroepithelial lesions revisited: implications for diagnosis and management.
Tan PH
Mod Pathol; 2021 Jan; 34(Suppl 1):15-37. PubMed ID: 32461622
[TBL] [Abstract][Full Text] [Related]
11. Gene expression-based classifications of fibroadenomas and phyllodes tumours of the breast.
Vidal M; Peg V; Galván P; Tres A; Cortés J; Ramón y Cajal S; Rubio IT; Prat A
Mol Oncol; 2015 Jun; 9(6):1081-90. PubMed ID: 25687451
[TBL] [Abstract][Full Text] [Related]
12. Phyllodes tumours of the breast: a consensus review.
Tan BY; Acs G; Apple SK; Badve S; Bleiweiss IJ; Brogi E; Calvo JP; Dabbs DJ; Ellis IO; Eusebi V; Farshid G; Fox SB; Ichihara S; Lakhani SR; Rakha EA; Reis-Filho JS; Richardson AL; Sahin A; Schmitt FC; Schnitt SJ; Siziopikou KP; Soares FA; Tse GM; Vincent-Salomon A; Tan PH
Histopathology; 2016 Jan; 68(1):5-21. PubMed ID: 26768026
[TBL] [Abstract][Full Text] [Related]
13. A study of fibroepithelial tumours of the breast.
Badhe BA; Iyengar KR; Alva N
Indian J Cancer; 2002; 39(3):91-6. PubMed ID: 12928563
[TBL] [Abstract][Full Text] [Related]
14. Paediatric fibroepithelial lesions revisited: pathological insights.
Tay TK; Chang KT; Thike AA; Tan PH
J Clin Pathol; 2015 Aug; 68(8):633-41. PubMed ID: 25998513
[TBL] [Abstract][Full Text] [Related]
15. Benign phyllodes tumour vs fibroadenoma: FNA cytological differentiation.
Veneti S; Manek S
Cytopathology; 2001 Oct; 12(5):321-8. PubMed ID: 11722512
[TBL] [Abstract][Full Text] [Related]
16. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
Lien HC; Huang CS; Yang YW; Jeng YM
Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
[TBL] [Abstract][Full Text] [Related]
18. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
[TBL] [Abstract][Full Text] [Related]
19. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates.
Zhang Y; Kleer CG
Arch Pathol Lab Med; 2016 Jul; 140(7):665-71. PubMed ID: 27362571
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast.
Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB
Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]